company

NEXT BIOMETRICS GROUP ASA

0155 OSLO

Return on Equity
−48,26 %
Current Ratio
4,35
Debt-to-Equity Ratio
0,01
Key figures (NOK)2022
Revenue48 292 000
Net Income−46 334 000
Total Assets121 850 000
Total Equity96 000 000
Income (NOK)2022
Revenue48 292 000
Expenditure96 362 000
Operating Profit−48 070 000
Financial Income1 794 000
Financial Costs118 000
Financial Balance1 676 000
Earnings Before Tax−46 394 000
Tax−60 000
Net Income−46 334 000
Balance (NOK)2022
Total Fixed Assets14 964 000
Total Current Assets106 886 000
Total Assets121 850 000
Total Retained Equity−30 000
Total Equity96 000 000
Total Long-Term Debt1 279 000
Total Current Debt24 571 000
Total Equity and Debt121 850 000
Cash flow (NOK)2022
Sales Income46 508 000
Other Income1 784 000
Revenue48 292 000
Cost of Goods Sold33 541 000
Salary Costs33 385 000
Depreciation7 229 000
Impairment0
Expenditure96 362 000
Operating Profit−48 070 000
Financial Income1 794 000
Financial Costs118 000
Financial Balance1 676 000
Dividends0
Net Income−46 334 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets2 617 000
Real Eastate12 347 000
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets12 347 000
Total Fiancial Fixed Assets0
Total Fixed Assets14 964 000
Stock22 935 000
Total Investments8 387 000
Cash, Bank69 302 000
Total Current Assets106 886 000
Total Assets121 850 000
Total Equity96 000 000
Short-Term Group Debt0
Total Long-Term Debt1 279 000
Creditors7 776 000
Unpaid Taxes143 000
Dividends0
Other Current Debt16 652 000
Total Current Debt24 571 000
Total Equity and Debt121 850 000
Financial indicators2022
Return on Equity−48,26 %
Debt-to-Equity Ratio0,01
Operating Profit Margin−99,54 %
Current Ratio4,35
Quick Ratio65,33
Equity Ratio0,79
Gross Profit Margin30,55 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English